Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes

Molecular and Cellular Biochemistry

Volumn 380, Issue 1-2, 2013, Pages 73-81

  Aydin, Suleyman ^a   Kuloglu, Tuncay ^a   Aydin, Suna ^a,b   Eren, Mehmet Nesimi ^c   Yilmaz, Musa ^a   Kalayci, Mehmet ^a   Sahin, Ibrahim ^a,d   Kocaman, Nevin ^a   Citil, Cihan ^a   Kendir, Yalcin ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b Elazig Training and Research Hospital   (Turkey)

^c DICLE UNIVERSITY   (Turkey)

^d ERZINCAN UNIVERSITY   (Turkey)

Author keywords

Adropin expression; Immunohistochemistry; Rat tissues; STZ induced diabetes

Indexed keywords

ADROPIN; PEPTIDE HORMONE; PHOSPHATE BUFFERED SALINE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CEREBELLUM; CONTROLLED STUDY; DIABETOGENESIS; ENDOCARDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPICARDIUM; GLIA CELL; GLOMERULUS; HEART; HEART MUSCLE; HUMIDITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY PARENCHYMA; LEYDIG CELL; LIGHT DARK CYCLE; LIVER; LIVER SINUSOID; NONHUMAN; ORGAN WEIGHT; PANCREAS; PIA MATER; PROTEIN EXPRESSION; PURKINJE CELL; QUANTITATIVE ANALYSIS; RAT; STREPTOZOCIN DIABETES; SUPERNATANT; TEMPERATURE; TISSUE LEVEL;

ANIMALS; BRAIN; CEREBELLUM; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; MALE; MYOCARDIUM; PANCREAS; PEPTIDES; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 84879799049     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1660-4     Document Type: Article

References (38)

1. Nicholson G, Hall GM (2011) Diabetes mellitus: new drugs for a new epidemic. Br J Anaesth 107:65-73
2. http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed March 2013
3. McNay EC, Teske JA, Kotz CM, Dunn-Meynell A, Levin BE, McCrimmon RJ, Sherwin RS (2013) Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance: a model for weight gain with intensive insulin therapy. Am J Physiol Endocrinol Metab 304:E131-E138
4. Aydin S (2013) Role of NUCB2/nesfatin-1 as a possible biomarker. Curr Pharm Des. PMID: 23537082
5. Aydin S (2010) The presence of the peptides apelin, ghrelin and nesfatin-1 in the human breast milk, and the lowering of their levels in patients with gestational diabetes mellitus. Peptides 31:2236-2240
6. Kuloglu T, Dabak DO (2009) Determination of ghrelin immunoreactivity in kidney tissues of diabetic rats. Ren Fail 31:562-566
7. Yang M, Zhang Z, Wang C, Li K, Li S, Boden G, Li L, Yang G (2012) Nesfatin-1 action in the brain increases insulin sensitivity through Akt/AMPK/TORC2 pathway in diet-induced insulin resistance. Diabetes 61:1959-1968
8. Luo KR, Chao CC, Hsieh PC, Lue JH, Hsieh ST (2012) Effect of glycemic control on sudomotor denervation in type 2 diabetes. Diabetes Care 35:612-616
9. Sokolovska J, Isajevs S, Sugoka O, Sharipova J, Paramonova N, Isajeva D, Rostoka E, Sjakste T, Kalvinsh I, Sjakste N (2012) Comparison of the effects of glibenclamide on metabolic parameters, GLUT1 expression, and liver injury in rats with severe and mild streptozotocin-induced diabetes mellitus. Medicina (Kaunas) 48:532-543
10. van de Ven KC, Tack CJ, Heerschap A, van der Graaf M, de Galan BE (2013) Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia. J Clin Invest 123:623-629
11. Zhang L, Xiong XQ, Fan ZD, Gan XB, Ago XY, Zhu GQ (2012) Involvement of enhanced cardiac sympathetic afferent reflex in sympathetic activation in early stage of diabetes. J Appl Physiol 113:47-55
12. Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, Kousoulas KG, Rogers PM, Kesterson RA, Thearle M, Ferrante AW Jr, Mynatt RL, Burris TP, Dong JZ, Halem HA, Culler MD, Heisler LK, Stephens JM, Butler AA (2008) Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab 8:468-481
13. Ganesh Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH, Culler MD, Mynatt RL, Butler AA (2012) Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring) 20:1394-1402
14. Celik E, Yilmaz E, Celik O, Ulas M, Turkcuoglu I, Karaer A, Celik ESimsek Y, Minareci Y, Aydin S (2013) Maternal and fetal adropin levels in gestational diabetes mellitus. J Perinat Med 1-6
15. Aydin S (2013) Presence of adropin, nesfatin-1, apelin-12, ghrelins and salusins peptides in the milk, cheese whey and plasma of dairy cows. Peptides 43:83-87
16. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique. J Histochem Cytochem 29:577-580
17. Aydin S, Ozercan IH, Geckil H, Dagli F, Aydin S, Kumru S, Kilic N, Sahin I, Ozercan MR (2007) Ghrelin is present in teeth. J Biochem Mol Biol 40:368-372
18. Kuloglu T, Aydin S (2013) Immunohistochemical expressions of adropin and inducible nitric oxide synthase in the renal tissues of rats with streptozotocin-induced experimental diabetes. Biotech Histochem (Submitted)
19. Gutierrez JC, Bahamonde J, Prater MR, Yefi CP, Holladay SD (2010) Production of a type 2 maternal diabetes rodent model using the combination of high-fat diet and moderate dose of streptozocin. Endocr Res 35:59-70
20. Celik A, Balin M, Kobat MA, Erdem K, Baydas A, Bulut M, Altas Y, Aydin S, Aydin S (2013) Deficiency of a new protein associated with cardiac syndrome X; called adropin. Cardiovasc Ther 3:174-178
21. Aberg ND, Brywe KG, Isgaard J (2006) Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J 6:53-80
22. Liu X, Yao DL, Bondy CA, Brenner M, Hudson LD, Zhou J, Webster HD (1994) Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol Cell Neurosci 5:418-430
23. Aydin S, Dag E, Ozkan Y, Erman F, Dagli AF, Kilic N, Sahin I, Karatas F, Yoldas T, Barim AO, Kendir Y (2009) Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 328:49-56
24. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M (2006) Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443:709-712
25. O'Carroll AM, Selby TL, Palkovits M, Lolait SJ (2000) Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 1492:72-80
26. Dagli AF, Aydin S, Karaoglu A, Akpolat N, Ozercan IH, Ozercan MR (2009) Ghrelin expression in normal kidney tissue and renal carcinomas. Pathol Res Pract 205:165-173
27. Day RT, Cavaglieri RC, Feliers D (2013) Apelin retards the progression of diabetic nephropathy. Am J Physiol Renal Physiol 6:53-80
28. Hus-Citharel A, Bouby N, Frugière A, Bodineau L, Gasc JM, Llorens-Cortes C (2008) Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int 74:486-494
29. Sahin I, Aydin S (2012) Serum concentration and kidney expression of salusin-α and salusin-β in rats with metabolic syndrome induced by fructose. Biotech Histochem 88:153-160
30. Aydin S, Eren MN, Aydin S, Ozercan IH, Dagli AF (2012) The bioactive peptides salusins and apelin-36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass. Peptides 37:233-239
31. Kleinz MJ, Davenport AP (2004) Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 118:119-125
32. Kleinz MJ, Skepper JN, Davenport AP (2005) Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 126:233-240
33. Dezaki K, Yada T (2012) Islet β-cell ghrelin signaling for inhibition of insulin secretion. Methods Enzymol 514:317-331
34. Dun SL, Brailoiu GC, Brailoiu E, Yang J, Chang JK, Dun NJ (2006) Distribution and biological activity of obestatin in the rat. J Endocrinol 191:481-489
35. Grönberg M, Tsolakis AV, Magnusson L, Janson ET, Saras J (2008) Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem 56:793-801
36. Drenckhahn D, Mannherz HG (1983) Distribution of actin and the actin-associated proteins myosin, tropomyosin, alpha-actinin, vinculin, and villin in rat and bovine exocrine glands. Eur J Cell Biol 30:167-176
37. Murakami K, Taniguchi H, Baba S (1982) Presence of insulin-like immunoreactivity and its biosynthesis in rat and human parotid gland. Diabetologia 22:358-361
38. Murakami K, Taniguchi H, Tamagawa M, Ejiri K, Baba S (1982) Modulation of somatostatin release by endogenous glucagon and insulin: physiological relationship between A, B and D cells in rat pancreatic islets. Endocrinol Jpn 29:503-508